Millipore Sigma Vibrant Logo

411455 Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6070)

This Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6070) is validated for use in ELISA for the detection of Human IgG₁, Fc Fragment Specific.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
411455
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
411455-400UG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 400 μg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      Catalogue Number411455
      Brand Family Calbiochem®
      References
      ReferencesHamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Jefferies, R., et al. 1986. Immunol. Letters 10, 223.
      Product Information
      FormLiquid
      FormulationAschites diluted in PBS, pH 7.4.
      PreservativeNone
      Quality LevelMQ100
      Applications
      Application ReferencesELISA Hamilton, R.G. 1987. Clin. Chem. 33, 1707.
      Application NotesELISA (see comments and application references)
      Application CommentsCan be used as a capture antibody for ELISA at 10 µg/ml in PBS without carrier protein. Antibody should be titrated for optimal results in individual systems.

      Cross-reactivity by ELISA against human myeloma proteins:
      Human IgG1: 100%
      Human IgG2: 0.1%
      Human IgG3: 0.1%
      Human IgG4: ≤0.02%
      Human IgA: ≤0.1%
      Human IgE: ≤0.1%
      Human IgM: ≤0.1%

      Cross-reactivity by ELISA against chimeric antibodies:
      Human IgG1: 100%
      Human IgG2: <0.01%
      Human IgG3: <0.01%
      Human IgG4: <0.01%
      Human IgA: <0.01%
      Human IgE: <0.001%
      Human IgM: <0.01%
      Biological Information
      CloneHP6070
      HostMouse
      IsotypeIgG₁
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      411455-400UG 07790788050061

      Documentation

      Mouse Anti-Human IgG₁, Fc Fragment Specific (HP6070) Certificats d'analyse

      TitreNuméro de lot
      411455

      Références bibliographiques

      Aperçu de la référence bibliographique
      Hamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Jefferies, R., et al. 1986. Immunol. Letters 10, 223.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-August-2007 JSW
      ApplicationELISA (see comments and application references)
      DescriptionMouse monoclonal antibody supplied as diluted ascites. Recognizes human IgG1 Fc fragment.
      BackgroundThe HP series of murine human Ig-specific monoclonal antibodies was produced from documented hybridoma cell lines that were developed at the Centers for Disease Control in Atlanta, Georgia. Laboratory analysis of each monoclonal antibody lot is performed in two stages during the production of ascites. First, the cell culture medium is analyzed for the presence and relative amount of human Ig-specific antibody by ELISA before injection of cells into mice. Second, collected ascites are analyzed for potency and antibody specificity using ELISA and isoelectric focusing (IEF), often in combination with an affinity immunoblot. For more information, the Calbiochem® technical monograph, The Human IgG Subclasses, is available free of charge.
      HostMouse
      CloneHP6070
      IsotypeIgG₁
      FormLiquid
      FormulationAschites diluted in PBS, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      PreservativeNone
      CommentsCan be used as a capture antibody for ELISA at 10 µg/ml in PBS without carrier protein. Antibody should be titrated for optimal results in individual systems.

      Cross-reactivity by ELISA against human myeloma proteins:
      Human IgG1: 100%
      Human IgG2: 0.1%
      Human IgG3: 0.1%
      Human IgG4: ≤0.02%
      Human IgA: ≤0.1%
      Human IgE: ≤0.1%
      Human IgM: ≤0.1%

      Cross-reactivity by ELISA against chimeric antibodies:
      Human IgG1: 100%
      Human IgG2: <0.01%
      Human IgG3: <0.01%
      Human IgG4: <0.01%
      Human IgA: <0.01%
      Human IgE: <0.001%
      Human IgM: <0.01%
      Storage Avoid freeze/thaw
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesHamilton, R.G. 1990. Ann. Biol. Clin. 48, 473.
      Fasullo, F.J., et al. 1989. Clin. Chem. 35, 364.
      Jefferies, R., et al. 1986. Immunol. Letters 10, 223.
      Application referencesELISA Hamilton, R.G. 1987. Clin. Chem. 33, 1707.